Abdirashid M. Shire, Ph.D.
Although his background is primarily in basic science research, Abdirashid M. Shire, Ph.D., of Mayo Clinic in Rochester, Minn., chose to study clinical and translational science because he wants to contribute to the rapid transfer of basic discoveries from the bench to the bedside.
The first stage of his research was a hospital-based study that identified a high frequency of hepatitis C virus infection in Minnesota's Somali immigrants. This discovery led to the understanding that arriving Somali refugees must be screened for this infection, with affected individuals given advice on treatment and surveillance.
As Dr. Shire continues his research, he is enjoying the protected research time and the didactic component of the KL2 Program, which is rounding out his capabilities. He also cites the multidisciplinary nature of Mayo as a notable benefit, saying, "The opportunity to interact with world-class faculty and obtain formal training in clinical research makes this a very attractive program."
Dr. Shire has been able to establish collaborations with other Mayo Clinic investigators conducting different projects with the Somali immigrant population. He is pleased with his progress so far, and says, "I'd like to emphasize the importance of this area and particularly encourage scholars from minority populations to pursue training in this growing field."
See Dr. Shire's publications on PubMed.